Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC

Clinical trial NCT06895811 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06895811
Sponsor: Shanghai Changzheng Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2025-03-27
Primary completion: 2026-07-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.